News Search Results
Apr 15, 2025, 07:01 ET MetaVia Announces Positive Top-Line Data From the 4-Week Phase 1 MAD Trial of DA-1726, a Novel 3:1 Ratio GLP-1 Glucagon Dual Receptor Agonist to Treat Obesity, Showing Compelling Weight Loss and Safety Effects With Potential Best-In-Class Glucose Control (GLP-1R), Waist Reduction (GCGR), and Tolerability
April 15, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced positive results from the 4-week multiple ascending dose (MAD) Part 2
More news about: MetaVia Inc.
Apr 15, 2025, 07:00 ET ThirtyFiveBio Closes Bridge Round of Financing Highlighted by Strategic New Investment from AbbVie Ventures
Kingdom, April 15, 2025 /PRNewswire/ -- ThirtyFiveBio Limited, a biotechnology company developing first-in-class small molecule inhibitors of G protein-coupled receptor 35 (GPR35) for the treatment of gastrointestinal (GI)
More news about: ThirtyFiveBio
Apr 15, 2025, 07:00 ET Leap Therapeutics to Host Virtual KOL Event to Discuss Sirexatamab (DKN-01) in Second-line Patients with Advanced Microsatellite Stable Colorectal Cancer
Mass., April 15, 2025 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced it will host a virtual key opinion leader (KOL) event featuring
More news about: Leap Therapeutics, Inc.
Apr 15, 2025, 04:00 ET myTomorrows and Scout Clinical Partner to Provide Cross-Border Patient Recruitment for Clinical Trials
education. Since 1995, we've been a trusted partner in customer service, regulatory compliance, and project delivery for leading pharmaceutical and biotechnology companies. Our deep understanding of international regulations and adaptable network of resources is built on operational experience in 109 countries.
More news about: myTomorrows and Scout Clinical
Apr 14, 2025, 21:00 ET JelloX Biotech Establishes US Research Base
Taiwan-based startup at the forefront of cancer pathology, is announcing it will open a lab in the Discovery Oasis biotechnology space in Phoenix, Arizona.
More news about: JelloX Biotech Inc.
Apr 14, 2025, 20:51 ET U.S. FDA grants interchangeable designation to YUFLYMA® (adalimumab-aaty), Celltrion's biosimilar to Humira® (adalimumab)
ZYMFENTRA® (infliximab-dyyb). Celltrion USA will continue to leverage Celltrion's unique heritage in biotechnology, supply chain excellence and best-in-class sales capabilities to improve access to high-quality biopharmaceuticals for U.S. patients. For more information,
More news about: Celltrion
Apr 14, 2025, 13:53 ET INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers - SANA
April 14, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Sana Biotechnology, Inc. ("Sana" or the "Company") (NASDAQ: SANA) and certain officers. The class action, filed in the United States
More news about: Pomerantz LLP
Apr 14, 2025, 10:07 ET ProBio to Present Data on Its CD3 Agonistic Single Domain Antibody Platform for Accelerated Development of T Cell Engager Multi-Specific Antibodies
development risks and accelerating timelines. One notable customer of ProBio’s antibody discovery platform is ABL Bio, a leading biotechnology company developing bispecific antibody therapeutics for immune-oncology and neurodegenerative diseases. Jonghwa Won, Ph.D., EVP and Chief
More news about: ProBio Inc.
Apr 14, 2025, 10:01 ET Glove Box Market to Reach $3.1 billion, Globally, by 2034 at 5.1% CAGR: Allied Market Research
projected to manifest the highest CAGR of 5.8% from 2025 to 2034. Pharmaceutical and biotechnology segment dominated the market in 2024 By end user, the pharmaceutical and biotechnology segment held the highest market share in 2024 accounting for the largest share in 2024, contributing
More news about: Allied Market Research
Apr 14, 2025, 09:51 ET SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sana Biotechnology, Inc. ("Sana" or "the Company") (NASDAQ:
More news about: The Schall Law Firm
Apr 14, 2025, 09:30 ET Skunk Works® and Arquimea Develop AI Capable ISR Platforms
Arquimea ARQUIMEA is a global technology company driven by innovation. We develop cutting-edge Artificial Intelligence, Quantum, Robotics and Biotechnology solutions and products for high-demand industries such as Aerospace and Defense & Security. Our research and development capabilities are supported
More news about: Lockheed Martin Aeronautics
Apr 14, 2025, 08:30 ET Cellenkos Announces US FDA Orphan Drug Designation Granted to CK0801 (Allogeneic Cord Blood derived T regulatory Cell Product) for Treatment of Aplastic Anemia
April 14, 2025 /PRNewswire/ -- Cellenkos® Inc., a clinical-stage biotechnology company focused on developing allogeneic, off-the-shelf, T regulatory (Treg) cell therapies for inflammatory disease areas of high unmet needs and
More news about: Cellenkos, Inc.
Apr 14, 2025, 08:30 ET Accord BioPharma, Inc. Announces Completion of UDENYCA® (pegfilgrastim-cbqv) Franchise Acquisition from Coherus BioSciences, Inc., Expanding U.S. Biosimilar Portfolio
India. Intas' biosimilars are manufactured at Intas Pharmaceuticals' European Union- Good Manufacturing Practices (EU-GMP) certified biotechnology plant located near Ahmedabad, Gujarat. For more information, visit
More news about: Accord BioPharma
Apr 14, 2025, 08:00 ET Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has received a Notice of Allowance from the United States Patent
More news about: Anixa Biosciences, Inc.
Apr 14, 2025, 08:00 ET Torrey Pines Law Group Recognized as a Leading Intellectual Property Law Firm by Chambers USA California Spotlight Guide 2025
transactions, and FDA regulatory compliance. The firm partners with technology innovators across industries such as artificial intelligence (AI), biotechnology, pharmaceuticals, diagnostics, digital health, medical devices, semiconductors, software, telecommunications, and wireless technologies. With offices
More news about: Torrey Pines Law Group
Apr 14, 2025, 07:30 ET Positive Outcome in 75% of CTCL Patients Treated with HyBryte™ for 18 Weeks
procurement contracts with the U.S. Government or other countries, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will
More news about: SOLIGENIX, INC.
Apr 14, 2025, 06:51 ET Ferulic Acid Market to Reach $104.2 Mn by 2027 in the short run and 167.1 Mn by 2035 globally, at 6% CAGR: Allied Market Research
report include Tokyo Chemical Industry Co., Ltd., Aktin Chemicals Inc., Pfaltz and Bauer, Inc., Spectrum Chemical Manufacturing Corp., Tianjin NWC Biotechnology Co., Ltd., Chemfaces, Sigma-Aldrich Corporation, Nomura Chemical Co., Ltd., and Merck KgaA. Explore AMR's Extensive ongoing Coverage on
More news about: Allied Market Research
Apr 14, 2025, 05:00 ET Chromatin Bioscience Signs Collaboration Agreement with Astellas
Bioscience. "We believe the ability to precisely control targeted gene expression is becoming increasingly critical across diverse applications in biotechnology. This collaboration reflects the growing interest in synthetic promoter technology as a key enabler in the development of precision-targeted biological
More news about: Chromatin Bioscience
Apr 14, 2025, 05:00 ET Chromatin Bioscience Signs Collaboration Agreement with Astellas
Bioscience. "We believe the ability to precisely control targeted gene expression is becoming increasingly critical across diverse applications in biotechnology. This collaboration reflects the growing interest in synthetic promoter technology as a key enabler in the development of precision-targeted biological
More news about: Chromatin Bioscience
Apr 14, 2025, 03:00 ET PRISM BioLab and Elix Join Forces to Accelerate AI-Driven Drug Discovery for Protein-Protein Interaction Targets
April 14, 2025 /PRNewswire/ -- PRISM BioLab, Co. Ltd. ("PRISM BioLab"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a drug discovery
More news about: PRISM BioLab Co., Ltd.
Apr 13, 2025, 09:03 ET SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sana Biotechnology, Inc. (NASDAQ: SANA) between March 17, 2023 and November 4, 2024, both dates inclusive
More news about: THE ROSEN LAW FIRM, P. A.
Apr 11, 2025, 13:00 ET WesternU COMP and COMP-Northwest named Tier 1 medical school for primary care for second consecutive year
Calif. and Lebanon, Ore., is an independent nonprofit health professions university, conferring degrees in biotechnology and pharmaceutical sciences, dental medicine, medical sciences, nursing, optometry, osteopathic medicine, pharmacy, physical therapy, physician
More news about: Western University of Health Sciences
Apr 11, 2025, 12:31 ET Global Times: Believing in China, believing in tomorrow
China's action.From launching pilot projects to expand opening-up in the fields of value-added telecommunications and biotechnology, to support domestic and foreign-funded enterprises equally in participating in large-scale equipment upgrades, consumer goods trade-in and other
More news about: Global Times
Apr 11, 2025, 10:23 ET ZINZINO AB (PUBL.): Zinzino acquires Valentus Global to increase distribution power in Europe
strategically important step in Zinzino's growth plans, which focus on improving personal health and well-being on a global scale with innovative biotechnology and a pioneering product portfolio marketed through direct sales. Valentus Global Inc. is a direct selling company based in Delaware,
More news about: Zinzino
Apr 11, 2025, 10:13 ET ZINZINO AB (PUBL.): Zinzino acquires Valentus Global to increase distribution power in Europe
strategically important step in Zinzino's growth plans, which focus on improving personal health and well-being on a global scale with innovative biotechnology and a pioneering product portfolio marketed through direct sales. Valentus Global Inc. is a direct selling company based in Delaware,
More news about: Zinzino